We develop antibody-based therapies targeting IL1RAP

See our pipeline
2025-03-26 Interview with H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

2025-03-26 Interview with H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

Interview with Interim CEO Damian Marron during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

Watch the interview here

Oppenheimer 35th Annual Healthcare Life Sciences Conference

Cantargia presented at Oppenheimer 35th Annual Healthcare Life Sciences Conference, February 11, 2025

Watch the event here
Oppenheimer 35th Annual Healthcare Life Sciences Conference

2025-02-07 Interview with Redeye

2025-02-07 Interview with Redeye

Interview with Interim CEO Damian Marron

Watch the interview here

2024-11-20 Redeye Redeye Autoimmune & inflammatory diseases event

CSO David Liberg presents at Redeye Autoimmune & inflammatory diseases event

Watch the presentation here
2024-11-20 Redeye Redeye Autoimmune & inflammatory diseases event


Current corporate presentation

Download the corporate presentation as PDF